Rapid Photochemical Cross-LinkingA New Tool for Studies of Metastable, Amyloidogenic Protein Assemblies
Top Cited Papers
- 17 March 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Accounts of Chemical Research
- Vol. 37 (6), 357-364
- https://doi.org/10.1021/ar000214l
Abstract
Amyloidoses comprise a class of diseases characterized pathologically by the presence of deposits of fibrillar, aberrantly folded proteins, known as amyloids. Historically, these deposits were considered the key factors causing disease. However, recent evidence suggests that soluble protein oligomers, which are precursors for amyloid fibrils, are the primary toxic effectors responsible for the disease process. Understanding the mechanism by which these oligomers exert their toxicity requires knowledge of the structure, kinetics, and thermodynamics of their formation and conversion into larger assemblies. Such studies have been difficult due to the metastable nature of the oligomers. For the amyloid β-protein (Aβ), a consensus about the size and relative abundance of small oligomers has not been achieved. We describe here the application of the method Photoinduced Cross-Linking of Unmodified Proteins (PICUP) to the study of Aβ oligomerization. This approach distinguishes oligomerization patterns of amyloidogenic and nonamyloidogenic proteins, allows quantification of each component in oligomer mixtures, and provides a means of correlating primary structure modifications with assembly characteristics. PICUP thus is a powerful tool for the investigation of small, metastable protein oligomers. The method provides essential insights into the factors that control the assembly of pathogenic protein oligomers, facilitating efforts toward the development of therapeutic agents.Keywords
This publication has 31 references indexed in Scilit:
- Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assembliesJournal of Neuroscience Research, 2002
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Amyloid β-Protein OligomerizationJournal of Biological Chemistry, 2001
- Protofibrils, the unifying toxic molecule of neurodegenerative disorders?Nature Neuroscience, 2001
- Protein misfolding and disease; protein refolding and therapyFEBS Letters, 2001
- Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?Trends in Neurosciences, 2001
- Aberrant Protein Deposition and Neurological DiseaseJournal of Biological Chemistry, 1999
- Human brain amyloidosesNephrology Dialysis Transplantation, 1998
- Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinBiochemical and Biophysical Research Communications, 1984
- Molecular pathology of the aging human brainTrends in Neurosciences, 1982